AI

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026

biotech

KTU chemists develop dual-action compounds to fight cancer

Jim Cornall - August 20, 2026

biotech

RSV antiviral drug receives FDA approval for phase II trial

Jim Cornall - August 20, 2026

biotech

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

Jim Cornall - August 19, 2026

AI

Disrupt.com to invest $100m into UAE AI startups

Jim Cornall - March 3, 2025

AI

Verint expands Global Innovation Center in India

Jim Cornall - February 21, 2025

AI

AI-driven breakthrough could accelerate bioeconomy

Jim Cornall - February 19, 2025

AI

iPRONICS raises €20m to advance optical networking

Jim Cornall - February 4, 2025

AI

VuNet raises $7m to boost global expansion and product innovation

Jim Cornall - January 29, 2025

AI

Pasqal and EDF address electric vehicle charging with quantum computing

Jim Cornall - January 23, 2025

AI

Perciv AI secures €2.5m to expand radar solutions

Jim Cornall - December 23, 2024

AI

NSAIT and ETH Zurich Entrepreneurs launch LogicStar AI

Jim Cornall - December 16, 2024

1...345...7 Page 4 of 7

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Base to Base biotech podcast 72: Cell-free DNA bioproduction

Jim Cornall - August 21, 2026 0

This week, we have a conversation about the Flexible Automation for Scalable Health (FLASH) programme, focused on the development of scalable cell-free DNA bioproduction...

KTU chemists develop dual-action compounds to fight cancer

biotech Jim Cornall - August 20, 2026 0

RSV antiviral drug receives FDA approval for phase II trial

biotech Jim Cornall - August 20, 2026 0

Research uncovers new driver of immunotherapy resistance in pancreatic cancer

biotech Jim Cornall - August 19, 2026 0

Pilot project between BioCytics and LIDE Biotech

biotech Jim Cornall - August 19, 2026 0